Curcugreen shown to be effective with osteoarthritis

13 Jun 2019

In a newly published human clinical study, Arjuna Natural curcumin formulation BCM-95 (Curcugreen) is said to have demonstrated new possibilities for effectively managing symptoms associated with osteoarthritis of the knee, and exhibited results that matched those of some of the non-steroidal anti-inflammatory drugs (NSAIDs) typically used for significantly reducing pain severity.

In addition, subjects in the study incurred none of the gastric side effects that can be associated with the use of NSAIDs. BCM-95 (Curcugreen) is a patented, high-potency turmeric extract developed by Arjuna.

Curcugreen shown to be effective with osteoarthritis

Osteoarthritis (OA) of the knee normally occurs in people beginning at about age 40, the company notes. It can have considerable restrictive impact on physical activity, and is the fourth leading cause of disability. After age 60, an estimated 10% to 15% of all adults have some degree of OA. The increasing prevalence of OA has been attributed to an ageing population and rising cases of obesity. Pain is commonly noted as the key symptom driving individuals to seek medical care.

The randomized, open-label, parallel-arm study was led by Dhaneshwar Shep, Ph.D., et. al., at the City Care Accident Hospital, Parli Vaijnath, Maharashtra, India, and was published in the journal Trials last March. The study involved 139 participants suffering from knee osteoarthritis They were given either 500mg BCM-95 three times daily, or 50 mg Volteran (diclofenac), twice daily for 28 days.

Within two weeks of treatment, BCM-95 (Curcugreen) demonstrated an ability to reduce pain and relieve joint stiffness with a secondary capacity to effect improvements in the daily functions of living, recreational sporting activity, and overall quality of life, all at a level similar to that achieved through the NSAID control. Curcumin’s therapeutic functions are essentially credited to its well-documented ability to suppress several pro-inflammatory cytokines and their release mediators.

“BCM-95 curcumin could be a favourable alternative for people seeking relief from OA symptoms, especially those who are intolerant to the side effects of standard OTC drugs,” said Benny Antony, Joint Managing Director of Arjuna.

In the same study, the BCM-95 group reported a significant reduction in episodes of flatulence (an unpleasant side effect common to some NSAIDs), and an anti-ulcerative effect of BCM-95 also was observed. None of the participants required heartburn drugs, such as the H2 blockers often prescribed alongside NSAIDs. Preclinical studies conducted on rats have previously demonstrated the gastroprotective properties of this anti-inflammatory polyphenolic compound used extensively in traditional Ayurvedic medicine.

Arjuna says that this is the first study in which curcumin therapy has elicited a significant positive link to osteoarthriticcare.

“The beneficial results obtained in the study are highly likely due to the combination of curcuminoids and essential oil of turmeric present in our proprietary curcumin formulation with increased curcumin bioavailability,” said Antony. “The permeability of curcumin is increased by the turmerone-rich essential oil complex, incurring a sevenfold enhancement of plasma curcumin levels, proven to yield statistically significant clinical benefits.”

Related news

EFSA declines to authorise GlycoLite claim

EFSA declines to authorise GlycoLite claim

17 Jun 2019

The EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to GlycoLite.

Read more 
DuPont launches cultures for plant-based products

DuPont launches cultures for plant-based products

7 May 2019

DuPont Nutrition & Biosciences has announced a new cultures line that contains its premium HOWARU probiotics which are specially designed for fermented plant-based products to deliver clinically backed health benefits.

Read more 
Neptune to offer turnkey hemp solutions

Neptune to offer turnkey hemp solutions

19 Apr 2019

Neptune Wellness Solutions has announced that its Solutions Business has begun offering turnkey product development solutions with hemp-derived ingredients to business customers in the United States.

Read more 
Innova sees plant-based sports nutrition growth

Innova sees plant-based sports nutrition growth

17 Apr 2019

There has been, according to Innova Market Insights, over 40% growth in new sports nutrition launches with a plant-based claim between 2014 and 2018.

Read more 
Arjuna gets curcumin patent

Arjuna gets curcumin patent

16 Apr 2019

Arjuna Natural has been granted a new European patent for its applied technology of improving the bioavailability of curcumin in its BCM-95 (Curcugreen) formulation.

Read more 
SternVitamin addresses 'Energy Drinks 4.0' market

SternVitamin addresses 'Energy Drinks 4.0' market

9 Apr 2019

SternVitamin is promoting individual micronutrient premixes for different consumer demands and applications. One such new product is Pure Vitalizer, designed for making “Energy Drinks 4.0”.

Read more 
DuPont completes new probiotics unit

DuPont completes new probiotics unit

1 Apr 2019

DuPont has announced it has completed the construction of a new probiotics fermentation unit - said to be the largest in the world - at its Rochester, New York, facility.

Read more 
Tate & Lyle collaborates on dietary fibre

Tate & Lyle collaborates on dietary fibre

20 Mar 2019

Tate & Lyle has announced a collaborative research project on the health effects of dietary fibres with APC Microbiome Ireland, a Science Foundation Institute (SFI) Research Centre.

Read more 
Arjuna Natural publishes amla study

Arjuna Natural publishes amla study

18 Mar 2019

A newly published study is said to demonstrate the efficacy and safety of Tri-Low full extract of amla (Phyllanthus emblica), the Indian gooseberry, in alleviating dyslipidemia.

Read more 
Lipofoods to launch microencapsulated botanical ingredients

Lipofoods to launch microencapsulated botanical ingredients

6 Mar 2019

Lipofoods is to introduce a new line of microencapsulated botanical ingredients supported by proprietary science for proven efficacy.

Read more